Guidelines for the control of methicillin-resistant Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 3, 1998, Pages 287-289

  Fraise, Adam P ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUSIDIC ACID; RIFAMPICIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BLOOD CULTURE; ENTEROCOCCUS; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; RISK FACTOR; SHORT SURVEY; SURGERY;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; GLYCOPEPTIDES; HUMANS; METHICILLIN RESISTANCE; PRACTICE GUIDELINES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0031659552     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.3.287     Document Type: Short Survey

References (26)

1. Combined Working Party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy. (1990). Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection 16, 351-77.
2. Pollock, A. V. (1988). Surgical prophylaxis - the emerging picture. Lancet i, 225-30.
3. Rubin, L. G., Tucci, V., Cercenado, E., Eliopoulos, G. & Isenberg, H. D. (1992). Vancomycin-resistant Enterococcus faecium in hospitalised children. Infection Control and Hospital Epidemiology 13, 700-5.
4. Hospital Infection Control Practices Advisory Committee. (1995). Recommendations for preventing the spread of vancomycin resistance. Morbidity and Mortality Weekly Report 44 RR-12, 1-13.
5. Thompson, R. L., Cabezudo, I. & Wenzel, R. P. (1982). Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Annals of Internal Medicine 97, 309-17.
6. Rahman, M. (1998). Alternatives to vancomycin in treating methicillin-resistant Staphylococcus aureus infections. Journal of Antimicrobial Chemotherapy 41, 325-8.
7. Hartman, B. J. & Tomasz, A. (1984). Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. Journal of Bacteriology 158, 513-6.
8. Brink, A. J., Huygens, F. & Van Rensburg, A. J. (1993). Alternative antimicrobial options against multiply resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 31, 180-2.
9. Chembers, H. F., Sachdeva, M. & Kennedy, S. (1990). Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of β-lactam antibiotics against methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 162, 705-10.
10. Markowitz, N., Quinn, E. L. & Saravolatz, L. D. (1992). Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Annals of Internal Medicine 117, 390-8.
11. Portier, H. (1990). A multicentre, open, clinical trial of a new intravenous formulation of fusidic acid in severe staphylococcal infections. Journal of Antimicrobial Chemotherapy 25, Suppl. B, 39-44.
12. Wheat, L. J., Kohler, R. B., White, A. L. & White, A. (1981). Effect of rifampin on nasal carriers of coagulase-positive staphylococci, Journal of Infectious Diseases 144, 177.
13. Maple, P. A. C., Hamilton-Miller, J. M. T. & Brumfitt, W. (1991). Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 35, 345-50.
14. Public Health Laboratory Service. (1995). Epidemic methicillin resistant Staphylococcus aureus. Communicable Disease Report Weekly 5, 165.
15. Sader, H. S., Pignatari, A. C., Hollis, R. J., Leme, I & Jones, R. N. (1993). Oxacillin- and quinolone-resistant Staphylococcus aureus in São Paulo, Brazil: a multicenter molecular epidemiology study. Infection Control and Hospital Epidemiology 14, 260-4.
16. Kayser, F. H. & Novak, J. (1987). In vitro activity of ciprofloxacin against Gram positive bacteria. American Journal of Medicine 82, Suppl. 4A, 33-9.
17. de Gorgolas, M., Aviles, P., Verdejo, C. & Fernandez Guerrero, M. L. (1995). Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis. Antimicrobial Agents and Chemotherapy 39, 953-7.
18. Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C., John, J. F., Korvick, J. A. et al. (1993). Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. American Journal of Medicine 94, 313-28.
19. Casewell, M. W. & Hill, R. L. R. (1986). Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid') - a controlled trial. Journal of Antimicrobial Chemotherapy 17, 365-72.
20. Darouiche, R., Wright, C., Hamill, R., Koza, M., Lewis, D. & Markowski, J. (1991). Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline - rifampin and topical mupirocin. Antimicrobial Agents and Chemotherapy 35, 1612-5.
21. Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. & Tenover, F. C. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy 40, 135-46.
22. Anonymous. (1997). Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. Morbidity and Mortality Weekly Report 46, 765-6.
23. Schwalbe, R. S., McIntosh, A. C., Qaiyumi, S., Johnson, J. A., Johnson, R. J., Furness, K. M. et al. (1996). In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrobial Agents and Chemotherapy 40, 2416-9.
24. Agouridas, C., Bonnefoy, A. & Chantot, J. F. (1995). In vitro activity of RU 004, a novel ketolide highly active against respiratory pathogens. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F158, p. 140. American Society for Microbiology, Washington, DC.
25. Zurenko, G. E., Yagi, B. H., Schaadt, R. D., Allison, J. W., Kilburn, J. O., Glickman, S. E. et al. (1996). In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrobial Agents and Chemotherapy 40, 839-45.
26. Johnson, A. P., Warner, M. & Speller, D. C. E. (1997). In-vitro activity of quinopristin/dalfopristin (Synercid) against isolates of Streptococcus pneumoniae, Staphylococcus aureus and Enterococcus spp. Journal of Antimicrobial Chemotherapy 40, 604-5.